InsidersTradesSigma
Track the Scandinavian ChemoTech AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares trade on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Scandinavian ChemoTech AB has recorded 4 insider filings. Market capitalisation: €96.2m. The latest transaction was disclosed on 18 June 2026 (Purchase). Among the most active insiders: APAC EQUITY MANAGEMENT PTE LTD. All data is openly available.
4
Insider Decl.
n/a
Thresholds
€168,701
4 ops.
Buy Volume
n/a
n/a
Sell Volume
37Σ signal
Fundamental score
Ranked 24,756 of 28,833 companies
26.0
score / 100
Value20
Quality32
FCF yld-4.3%
Earn yld-8.4%
EV/EBITDA·
ROE-236%
Gross mgn84%
Net mgn-66%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 June 2026
Declarations4 total
74,626 shares@ SEK 3.350.024% mcap100.0% of flowAktieISIN SE0009382989FI:csv-85d979fefbb0d4a7bde6
223,880 shares@ SEK 3.350.074% mcap93.9% of flowAktieISIN SE0009382989FI:csv-00f6ecccfdaced2fe37a
238,805 shares@ SEK 3.35100.0% of flowAktieISIN SE0009382989FI:csv-440fd9a78f695a4982a0
12,611 shares@ €0.35030.0048% mcap100.0% of flowAktieISIN SE0009242654FI:A003U613-1
4 of 4 declarations
About Scandinavian ChemoTech AB
Scandinavian ChemoTech AB is a company focused on developing innovative cancer treatments. It specializes in enhanced chemotherapy solutions and targeted treatment technologies.